Spautin-1 inhibits the growth of diffuse large B-cell lymphoma by inducing mitochondrial damage-mediated PANoptosis and anti-tumor immunity
Abstract The prognosis of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) is poor. Therefore, searching for new therapeutic agents is particularly important to improve therapeutic efficacy. Targeting the ubiquitin-proteasome system is a potential therapeutic strategy for treating DLBCL....
Na minha lista:
| Principais autores: | , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Springer
2025-08-01
|
| Serier: | Cancer Immunology, Immunotherapy |
| Fag: | |
| Online adgang: | https://doi.org/10.1007/s00262-025-04150-9 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|